Common Contracts
8 similar Security Agreement contracts by Predictive Oncology Inc., 4Less Group, Inc., Major League Football Inc, others
COMMON STOCK PURCHASE WARRANT MAJOR LEAGUE FOOTBALL, INC.Security Agreement • September 7th, 2022 • Major League Football Inc • Services-amusement & recreation services • California
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the common stock purchase agreement dated August 31, 2022, in the amount of $2,500,000 by the Company (as defined below) to the Investor (as defined below)) (the “Agreement”), JANBELLA GROUP LLC (the “Investor” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from MAJOR LEAGUE FOOTBALL, INC., a Delaware corporation (the “Company”), up to $2,500,000 dollars of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof.
COMMON STOCK PURCHASE WARRANT The 4Less Group, Inc.Security Agreement • July 29th, 2021 • 4Less Group, Inc. • Services-business services, nec • California
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the common stock purchase agreement dated July 26, 2021, in the amount of $1,000,000 by the Company (as defined below) to the Investor (as defined below)) (the “Agreement”), TRITON FUNDS LP (the “Investor” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from The 4Less Group, Inc., a Nevada corporation (the “Company”), up to 300,000 shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof.
COMMON STOCK PURCHASE WARRANT Wikisoft Corp.Security Agreement • June 11th, 2021 • Wikisoft Corp. • Services-computer processing & data preparation • California
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value committed to (in connection with the common stock purchase agreement June 7, 2021, in the amount of $750,000 by the Company (as defined below) to the Investor (as defined below)) (the “Agreement”), TRITON FUNDS LP (the “Investor” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from Wikisoft Corp., a Nevada corporation (the “Company”), 500,000 shares of the Company’s common stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof.
COMMON STOCK PURCHASE WARRANT VNUE, INC.Security Agreement • May 4th, 2021 • VNUE, Inc. • Services-motion picture & video tape distribution • California
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value committed to (in connection with the common stock purchase agreement April 28, 2021, in the amount of $1,000,000 by the Company (as defined below) to the Investor (as defined below)) (the “Agreement”), TRITON FUNDS LP (the “Investor” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from VNUE, Inc., a Nevada corporation (the “Company”), $1,000,000 of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof.
COMMON STOCK PURCHASE WARRANT PREDICTIVE ONCOLOGY INC.Security Agreement • April 6th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of that certain senior secured convertible promissory note dated February 5, 2020, in the original principal amount of up to $1,450,000.00 by the Company (as defined below) to the Lender (as defined below)) (the “Note”), Oasis Capital, LLC, a Puerto Rico limited liability company (the “Lender” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from Predictive Oncology, Inc., a Delaware corporation (the “Company”), up to 92,700 shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof. This Warrant is issued by
COMMON STOCK PURCHASE WARRANT PREDICTIVE ONCOLOGY INC.Security Agreement • February 7th, 2020 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of that certain senior secured convertible promissory note dated February 5, 2020, in the original principal amount of up to $1,450,000.00 by the Company (as defined below) to the Lender (as defined below)) (the “Note”), Oasis Capital, LLC, a Puerto Rico limited liability company (the “Lender” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from Predictive Oncology, Inc., a Delaware corporation (the “Company”), up to 94,631 shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof. This Warrant is issued by
COMMON STOCK PURCHASE WARRANT RIOT BLOCKCHAIN, INC.Security Agreement • February 1st, 2019 • Riot Blockchain, Inc. • In vitro & in vivo diagnostic substances • Kansas
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of that certain senior secured convertible promissory note dated January 28, 2019, in the original principal amount of up to [$________] by the Company (as defined below) to the Lender (as defined below)) (the “Note”), [___________] (the “Lender” and including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the Exercise Period, to purchase from Riot Blockchain, Inc., a Nevada corporation (the “Company”), up to [_________] shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect. The number of Warrant Shares for which this Warrant may be exercised is subject to adjustment in accordance with the terms hereof. This Warrant is issued by the Company as of the date hereof pursuant to the
COMMON STOCK PURCHASE WARRANT PRECISION THERAPEUTICS INC.Security Agreement • October 4th, 2018 • Precision Therapeutics Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Kansas
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the funding of the purchase price of $1,400,000.00, with respect to the first tranche of $1,615,908.70 under that certain convertible promissory note in the original principal amount of $2,013,635.75 on September 28, 2018 by the Company (as defined below) to the Holder (as defined below)) (the “Note”), L2 Capital, LLC, a Kansas limited liability company (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Precision Therapeutics Inc., a Delaware corporation (the “Company”), up to 939,261 shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) (with the understanding that the H
